EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction

James R M Black, Takahiro Karasaki, Charles W Abbott, Bailiang Li, Selvaraju Veeriah, Maise Al Bakir, Wing Kin Liu, Ariana Huebner, Carlos Martínez-Ruiz, Piotr Pawlik, David A Moore, Daniele Marinelli und 27 weitere

Cell · 2025-12 · 188 (25) · 7083-7098.e18

DOI: 10.1016/j.cell.2025.10.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-12. Verfasst von James R M Black und 38 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability …. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Francis Crick Institute, Horizon 2020 Framework Programme, Imperial Experimental Cancer Medicine Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomarkers accurately informing prognostic assessment and therapeutic strategy are critical for improving patient outcome in oncology. Here, we apply a whole-genome, tumor-informed circulating tumor DNA (ctDNA) detection approach to address this challenge, leveraging 1,800 variants across 2,994 plasma samples from 431 patients with non-small cell lung cancer (NSCLC) from the TRACERx study. We show that ultrasensitive ctDNA detection below 80 parts per million both pre- and postoperatively is highly prognostic, and combinatorial analysis of the pre- and postoperative ctDNA status identifies an intermediate risk group, improving disease stratification. ctDNA kinetics demonstrate clinical utility during adjuvant therapy, where patients that "clear" ctDNA during adjuvant therapy experience improved outcomes. Moreover, characterization of patterns in postoperative ctDNA kinetics reveals insights into the timing, risk, and anatomical pattern of relapses. By incorporating longitudinal ultrasensitive ctDNA detection, we propose a refined schema for guiding the stratification and treatment recommendations in early stage NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Circulating Tumor DNALung NeoplasmsCarcinoma, Non-Small-Cell LungHumansBiomarkers, TumorMaleFemalePrognosisMiddle AgedAgedNeoplasm Recurrence, LocalLongitudinal Studies

Stichwörter der Autor:innen

circulating tumor DNAliquid biopsymolecular residual diseasenon-small cell lung cancerprognostic classificationtherapy response prediction/monitoring

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Tho…
  • Personalis Inc., Fremont, CA, USA.
  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Onc…
  • Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.
  • Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.

Förderung

  • Francis Crick Institute
  • Horizon 2020 Framework Programme
  • Imperial Experimental Cancer Medicine Centre
  • Canadian Institutes of Health Research
  • European Research Council
  • Royal Society
  • Mark Foundation For Cancer Research
  • Wellcome Trust

Zitieren

APA

Black, J. R. M., Karasaki, T., Abbott, C. W., Li, B., Veeriah, S., Al Bakir, M., Liu, W. K., Huebner, A., Martínez-Ruiz, C., Pawlik, P., Moore, D. A., Marinelli, D., Shutkever, O., Murphy, C., Liu, L. Y., Grieco, C., Grimes, K., Navarro, F. C. P., Pyke, R. M., …, & Swanton, C. (2025). Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction. Cell, 188(25), 7083-7098.e18. https://doi.org/10.1016/j.cell.2025.10.020

Vancouver

Black JRM, Karasaki T, Abbott CW, Li B, Veeriah S, Al Bakir M, et al. Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction. Cell. 2025;188(25):7083-7098.e18. doi:10.1016/j.cell.2025.10.020

BibTeX
@article{Black2025,
  author = {Black, James R M and Karasaki, Takahiro and Abbott, Charles W and Li, Bailiang and Veeriah, Selvaraju and Al Bakir, Maise and Liu, Wing Kin and Huebner, Ariana and Martínez-Ruiz, Carlos and Pawlik, Piotr and Moore, David A and Marinelli, Daniele and Shutkever, Oliver and Murphy, Cian and Liu, Lydia Y and Grieco, Charlotte and Grimes, Karen and Navarro, Fabio C P and Pyke, Rachel Marty and Bartha, Gabor and Keough, Kathleen C and Dea, Steven and Ravi, Neeraja and Lyle, John and Harris, Jason and Brown, Katherine D and Blackhall, Fiona H and Hassani, Fatemah and Fennell, Dean A and McGranahan, Nicholas and Shaw, Jacqui A and Abbosh, Christopher and TRACERx Consortium, TRACERx Consortium and Hackshaw, Allan and Jamal-Hanjani, Mariam and Frankell, Alexander M and Boyle, Sean M and Chen, Richard O and Swanton, Charles},
  title = {Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {25},
  pages = {7083--7098.e18},
  doi = {10.1016/j.cell.2025.10.020}
}
Kostenlos starten →